This is not the most recent version of the article. View current version (13 MAR 2014)

Intervention Review

You have free access to this content

Vaccines for preventing influenza in healthy adults

  1. Vittorio Demicheli2,
  2. Carlo Di Pietrantonj3,
  3. Tom Jefferson4,
  4. Alessandro Rivetti3,
  5. Daniela Rivetti1,*

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 18 APR 2007

Assessed as up-to-date: 8 JAN 2006

DOI: 10.1002/14651858.CD001269.pub3

How to Cite

Demicheli V, Di Pietrantonj C, Jefferson T, Rivetti A, Rivetti D. Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD001269. DOI: 10.1002/14651858.CD001269.pub3.

Author Information

  1. 1

    Servizio di Igiene e Sanita' Pubblica, ASL 19 Asti, Public Health Department, Asti, Italy

  2. 2

    Regione Piemonte - Azienda Sanitaria Locale ASL AL, Health Councillorship - Servizio Regionale di Riferimento per l'Epidemiologia, SSEpi-SeREMI - Cochrane Vaccines Field, Torino, Piemonte, Italy

  3. 3

    Azienda Sanitaria Locale ASL AL, Servizio Regionale di Riferimento per l'Epidemiologia, SSEpi-SeREMI - Cochrane Vaccines Field, Alessandria, Piemonte, Italy

  4. 4

    The Cochrane Collaboration, Vaccines Field, Roma, Italy

*Daniela Rivetti, Public Health Department, Servizio di Igiene e Sanita' Pubblica, ASL 19 Asti, Via Conte Verde, 125, Asti, 14100, Italy. epidemiologia@asl.at.it.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 APR 2007

SEARCH

This is not the most recent version of the article. View current version (13 MAR 2014)

[Analysis 1.1]
Analysis 1.1. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 1 Influenza-like illness.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 2 Influenza.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 3 Physician visits.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 4 Days ill.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 5 Times any drugs were prescribed.
[Analysis 1.6]
Analysis 1.6. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 6 Times antibiotic was prescribed.
[Analysis 1.7]
Analysis 1.7. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 7 Working days lost.
[Analysis 1.8]
Analysis 1.8. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 8 Hospitalisations.
[Analysis 1.9]
Analysis 1.9. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 9 Pneumonia.
[Analysis 1.10]
Analysis 1.10. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 10 Clinical cases (clinically defined without clear definition).
[Analysis 1.11]
Analysis 1.11. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 11 Local harms.
[Analysis 1.12]
Analysis 1.12. Comparison 1 Inactivated parenteral vaccine versus placebo or do-nothing, Outcome 12 Systemic harms.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Live aerosol vaccine versus placebo or do-nothing, Outcome 1 Influenza-like illness.
[Analysis 2.2]
Analysis 2.2. Comparison 2 Live aerosol vaccine versus placebo or do-nothing, Outcome 2 Influenza.
[Analysis 2.3]
Analysis 2.3. Comparison 2 Live aerosol vaccine versus placebo or do-nothing, Outcome 3 Complications (bronchitis, otitis, pneumonia).
[Analysis 2.4]
Analysis 2.4. Comparison 2 Live aerosol vaccine versus placebo or do-nothing, Outcome 4 Influenza cases (clinically defined without clear definition).
[Analysis 2.5]
Analysis 2.5. Comparison 2 Live aerosol vaccine versus placebo or do-nothing, Outcome 5 Local harms.
[Analysis 2.6]
Analysis 2.6. Comparison 2 Live aerosol vaccine versus placebo or do-nothing, Outcome 6 Systemic harms.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Inactivated aerosol vaccine versus placebo or do-nothing, Outcome 1 Influenza-like illness.
[Analysis 3.2]
Analysis 3.2. Comparison 3 Inactivated aerosol vaccine versus placebo or do-nothing, Outcome 2 Local harms.
[Analysis 3.3]
Analysis 3.3. Comparison 3 Inactivated aerosol vaccine versus placebo or do-nothing, Outcome 3 Systemic harms.
[Analysis 4.1]
Analysis 4.1. Comparison 4 1968 to 1969 pandemic: Inactivated polyvalent parenteral vaccine versus placebo, Outcome 1 Influenza-like illness.
[Analysis 4.2]
Analysis 4.2. Comparison 4 1968 to 1969 pandemic: Inactivated polyvalent parenteral vaccine versus placebo, Outcome 2 Influenza.
[Analysis 4.3]
Analysis 4.3. Comparison 4 1968 to 1969 pandemic: Inactivated polyvalent parenteral vaccine versus placebo, Outcome 3 Hospitalisations.
[Analysis 4.4]
Analysis 4.4. Comparison 4 1968 to 1969 pandemic: Inactivated polyvalent parenteral vaccine versus placebo, Outcome 4 Pneumonia.
[Analysis 5.1]
Analysis 5.1. Comparison 5 1968 to 1969 pandemic: Inactivated monovalent parenteral vaccine versus placebo, Outcome 1 Influenza-like illness.
[Analysis 5.2]
Analysis 5.2. Comparison 5 1968 to 1969 pandemic: Inactivated monovalent parenteral vaccine versus placebo, Outcome 2 Influenza.
[Analysis 5.3]
Analysis 5.3. Comparison 5 1968 to 1969 pandemic: Inactivated monovalent parenteral vaccine versus placebo, Outcome 3 Hospitalisations.
[Analysis 5.4]
Analysis 5.4. Comparison 5 1968 to 1969 pandemic: Inactivated monovalent parenteral vaccine versus placebo, Outcome 4 Pneumonia.
[Analysis 5.5]
Analysis 5.5. Comparison 5 1968 to 1969 pandemic: Inactivated monovalent parenteral vaccine versus placebo, Outcome 5 Working days lost.
[Analysis 5.6]
Analysis 5.6. Comparison 5 1968 to 1969 pandemic: Inactivated monovalent parenteral vaccine versus placebo, Outcome 6 Days ill.
[Analysis 6.1]
Analysis 6.1. Comparison 6 1968 to 1969 pandemic: Inactivated polyvalent aerosol vaccine versus placebo, Outcome 1 Influenza-like illness.
[Analysis 7.1]
Analysis 7.1. Comparison 7 1968 to 1969 pandemic: Inactivated monovalent aerosol vaccine versus placebo, Outcome 1 Influenza-like illness.
[Analysis 8.1]
Analysis 8.1. Comparison 8 1968 to 1969 pandemic: Live aerosol vaccine versus placebo, Outcome 1 Influenza cases (clinically defined without clear definition).
[Analysis 8.2]
Analysis 8.2. Comparison 8 1968 to 1969 pandemic: Live aerosol vaccine versus placebo, Outcome 2 Complications (bronchitis, otitis, pneumonia).